The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The psychopharmacology of agitation: consensus statement of the American association for emergency psychiatry project BETA psychopharmacology workgroup
Open accessAbstract
To the Editor: We were excited to read the article by Michael Wilson et al1 in the March 2012 issue of the Western Journal of Emergency Medicine regarding pharmacologic strategies for the management of agitated patients in the emergency setting. This article highlights several important points including the optimal management of stimulant-induced agitation and the feasibility of and reasons for differentiating acute alcohol intoxication from withdrawal, as optimal pharmacologic interventions for each might vary. While the authors correctly highlight the importance of preferential use of benzodiazepines to calm patients intoxicated with most recreational drugs, we believe that the use of benzodiazepines as first line treatment for agitation should be extended to include that from acute overdose of other agents. Because many common medications taken in acute overdose, such as cyclic antidepressants, SSRIs, diphenhydramine and other over-the-counter medications have toxicity profiles that include anticholinergic, proconvulsant, hyperthermic, and cardiotoxic (QTc prolongation) properties, which overlap with antipsychotics, we recommend benzodiazepines as first, second and third line for agitation in these instances to avoid contributing to these potentially life threatening adverse effects. Further, benzodiazepines raise the seizure threshold and promote conditions that precipitate heat dissipation.2,3 If, after liberal use of benzodiazepines, the patient still displays agitation necessitating further pharmacologic intervention, we then use antipsychotics with caution. We found the reported maximum daily dose of lorazepam in the Table1 to be dangerously low. We were glad to see the emphasis on patient and staff safety, given the increasing awareness of the excited delirium syndrome, thought to be due to a multifactorial interaction of delirium and agitation often secondary to stimulant intoxication, leading to hyperthermia, profound acidemia and sometimes death.4-7 We regret that the authors left out a discussion of the increasing use of the dissociative agent ketamine for rapid control of dangerous behavior in this subset of patients. Although no controlled trials exist regarding its use in agitated patients, several case reports show rapid, satisfactory results without significant respiratory and cardiovascular adverse effects.5,8 Potential adverse effects of ketamine, although uncommon, include hypertension, emergence phenomena, increased oral secretions and laryngospasm.7,10 Hannah Hays, MD* Heath A. Jolliff, DO, FACEP, FAAEM * Marcel J. Casavant, MD, FACEP, FACMT †
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Which medications to avoid in people at risk of delirium: a systematic review
Clegg, A., & Young, J. B. (2011) · Age and Ageing · doi:10.1093/ageing/afq140 · Cited by 552
Wilson, M., Pepper, D., Currier, G., Holloman, G., & Feifel, D. (2012) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2011.9.6866 · Cited by 402
Tardive dyskinesia and new antipsychotics
Correll, C. U., & Schenk, E. M. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f53132 · Cited by 367
Lonergan, E., Britton, A. M., & Luxenberg, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005594.pub2 · Cited by 361
Battaglia, J., Moss, S., Rush, J., Kang, J., Mendoza, R., Leedom, L., Dubin, W., McGlynn, C., & Goodman, L. (1997) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(97)90119-4 · Cited by 350
Adverse events associated with ketamine for procedural sedation in adults
Strayer, R. J., & Nelson, L. S. (2008) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2007.12.005 · Cited by 325
Tardive dyskinesia and new antipsychotics
Correll, C. U., & Schenk, E. M. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e328303e7a6 · Cited by 289
Breier, A., Meehan, K., Birkett, M., David, S., Ferchland, I., Sutton, V., Taylor, C. C., Palmer, R., Dossenbach, M., Kiesler, G., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.441 · Cited by 289
Introduction: Methods, Commentary, and Summary
ALLEN, M. H., CURRIER, G. W., CARPENTER, D., ROSS, R. W., & DOCHERTY, J. P. (2005) · Journal of Psychiatric Practice · doi:10.1097/00131746-200511001-00002 · Cited by 267
Pharmacological Management of Acute Agitation
Battaglia, J. (2005) · Drugs · doi:10.2165/00003495-200565090-00003 · Cited by 254
Benzodiazepines for alcohol withdrawal
Amato, L., Minozzi, S., Vecchi, S., & Davoli, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005063.pub3 · Cited by 245
Anesthesia for Electroconvulsive Therapy
Grundmann, U. (2017) · Essentials of Neuroanesthesia · doi:10.1016/b978-0-12-805299-0.00048-8 · Cited by 205
Overview of Project BETA: Best practices in Evaluation and Treatment of Agitation
Holloman, G., & Zeller, S. (2012) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2011.9.6865 · Cited by 188
Martel, M., Sterzinger, A., Miner, J., Clinton, J., & Biros, M. (2005) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2005.tb01492.x · Cited by 170
Benzodiazepines for alcohol withdrawal
Ntais, C., Kyzas, P., Pakos, E., & Ioannidis, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005063 · Cited by 165
The clinical toxicology of metamfetamine
Schep, L. J., Slaughter, R. J., & Beasley, D. M. G. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.516752 · Cited by 164
Huf, G., Coutinho, E. S. F., & Adams, C. E. (2007) · BMJ · doi:10.1136/bmj.39339.448819.ae · Cited by 157
A Survey of Workplace Violence Across 65 U.S. Emergency Departments
Kansagra, S. M., Rao, S. R., Sullivan, A. F., Gordon, J. A., Magid, D. J., Kaushal, R., Camargo, C. A., & Blumenthal, D. (2008) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2008.00282.x · Cited by 152
Haloperidol plus promethazine for psychosis-induced aggression
Huf, G., Alexander, J., Gandhi, P., & Allen, M. H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005146.pub3 · Cited by 151
Acute Treatment of Psychotic Agitation
Currier, G. W., Chou, J. C.-Y., Feifel, D., Bossie, C. A., Turkoz, I., Mahmoud, R. A., & Gharabawi, G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0315 · Cited by 139
Recognition and management of complications of new recreational drug use
Ricaurte, G. A., & McCann, U. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66737-2 · Cited by 135
Evidence-based review of the black-box warning for droperidol
Jackson, C. W., Sheehan, A. H., & Reddan, J. G. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060505 · Cited by 129
Haloperidol for sedation of disruptive emergency patients
Clinton, J. E., Sterner, S. P., Stelmachers, Z. T., & Ruiz, E. (1987) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(87)80179-8 · Cited by 114
Role of α 2 -Agonists in the Treatment of Acute Alcohol Withdrawal
Muzyk, A. J., Fowler, J. A., Norwood, D. K., & Chilipko, A. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p575 · Cited by 107
Calming versus sedative effects of intramuscular olanzapine in agitated patients
Battaglia, J., Lindborg, S. R., Alaka, K., Meehan, K., & Wright, P. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(02)42249-8 · Cited by 106
Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane, J. M. (2004) · PubMed · Cited by 104
Dolder, C. R., & Jeste, D. V. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00170-7 · Cited by 102
Hypothermia following antipsychotic drug use
van Marum, R. J., Wegewijs, M. A., LOONEN, A. J. M., & Beers, E. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0294-4 · Cited by 98
Acute Respiratory Failure from Abused Substances
Wilson, K. C., & Saukkonen, J. J. (2004) · Journal of Intensive Care Medicine · doi:10.1177/0885066604263918 · Cited by 94
Toxicological Interactions Between Alcohol and Benzodiazepines
Tanaka, E. (2002) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120002887 · Cited by 89
Hsu, W., Huang, S., Lee, B., & Chiu, N.-Y. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db8715 · Cited by 82
Treatment for amphetamine psychosis
SHOPTAW, S. J., Kao, U. H., & Ling, W. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003026.pub3 · Cited by 72
Pharmacological Treatment of Psychotic Agitation
Currier, G. W., & Trenton, A. (2002) · CNS Drugs · doi:10.2165/00023210-200216040-00002 · Cited by 66
Cong, M. L., Gynther, B., Hunter, E. M., & Schuller, P. J. (2011) · Emergency Medicine Journal · doi:10.1136/emj.2010.107946 · Cited by 66
Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis
Gillies, D. M., Beck, A., & McCloud, A. (2001) · doi:10.1002/14651858.cd003079 · Cited by 65
Chang, G., Weiss, A. P., Orav, E. J., Jones, J. A. M., Finn, C. T., Gitlin, D. F., Haimovici, F., Hazen, E. P., Kosowsky, J. M., Schechter, M., et al. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.12.003 · Cited by 63
Marder, S. R., Sorsaburu, S., Dunayevich, E., Karagianis, J. L., Dawe, I. C., Falk, D. M., Dellva, M. A., Carlson, J. L., Cavazzoni, P. A., & Baker, R. W. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04411gry · Cited by 59
VIOLENT PATIENTS IN THE EMERGENCY SETTING
Citrome, L., & Volavka, J. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70126-x · Cited by 59
Lim, H. K., Kim, J. J., Pae, C. U., Lee, C. U., Lee, C., & Paik, I. H. (2010) · Neuropsychobiology · doi:10.1159/000315437 · Cited by 57
MacDonald, K. S., Wilson, M. P., Minassian, A., Vilke, G. M., Perez, R., Cobb, P., Tallian, K. B., Becker, O. V., & Feifel, D. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.04.005 · Cited by 47
Roberts, J. R., & Geeting, G. K. (2001) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-200111000-00031 · Cited by 45
Lambert, M., SCHIMMELMANN, B. G., Karow, A., & Naber, D. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45128 · Cited by 43
Wilson, M. P., MacDonald, K. S., Vilke, G. M., & Feifel, D. (2010) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2010.04.012 · Cited by 42
Ziprasidone for the Treatment of Acute Manic or Mixed Episodes Associated with Bipolar Disorder
Warrington, L. E., Lombardo, I., Loebel, A. D., & Ice, K. S. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00004 · Cited by 30
What Would The Patient Choose? Subjective Comparison of Atypical and Typical Neuroleptics
Karow, A., Schnedler, D., & Naber, D. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-931541 · Cited by 28
Currier, G. W., Trenton, A., Walsh, P., & van Wijngaarden, E. (2006) · Journal of Psychiatric Practice · doi:10.1097/00131746-200607000-00004 · Cited by 24
Cited by
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Assessment and management of agitation in psychiatry: Expert consensus
Garriga, M., Pacchiarotti, I., Kasper, S., Zeller, S. L., Allen, M. H., Vázquez, G., Baldaçara, L., San, L., McAllister-Williams, R. H., Fountoulakis, K. N., et al. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1132007 · Cited by 309
Roppolo, L. P., Morris, D. W., Khan, F., Downs, R., Metzger, J., Carder, T., Wong, A. H., & Wilson, M. P. (2020) · JACEP Open · doi:10.1002/emp2.12138 · Cited by 130
Richards, J. R., Albertson, T. E., Derlet, R. W., Lange, R. A., Olson, K. R., & Horowitz, B. Z. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.040 · Cited by 107
Antipsychotics for the treatment of sympathomimetic toxicity: A systematic review
Connors, N. J., Alsakha, A., Larocque, A., Hoffman, R. S., Landry, T., & Gosselin, S. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.01.001 · Cited by 23
Metadata
- Authors
- Hays, H., Jolliff, H., & Casavant, M.
- Venue
- Western Journal of Emergency Medicine
- Published
- 2012-12-01
- Volume
- 13
- Issue
- 6
- Pages
- 536-537
- ISSN
- 1936-900X (ISSN-L)
- 1936-9018
- OpenAlex
- W2130649501
- Cited by
- 271
- References
- 46
- FWCI
- 20.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.